ADHDBRIDGE-ADHDNCT07926776
Supporting Families of School-Aged Children With ADHD: A Dual-Generation Therapy Approach Through the BRIDGE Program
A study testing BRIDGE-ADHD in people with ADHD and Maternal Mental Health, run by University of Manitoba at 1 site in Canada.
Trial summary
The present research study will evaluate the feasibility and preliminary efficacy of the adapted Building Regulation in Dual Generations program for families of children (8-12 years old) with Attention-Deficit/Hyperactivity Disorder, creating the BRIDGE-ADHD program. Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- ADHD, Maternal Mental Health, Dialectical Behavior Therapy
- What is being tested?
- BRIDGE-ADHD
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteCanada
- Study dates
- 1 Nov 2026to 31 May 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Mothers must be 18 years old or older with both current and elevated symptoms of depression (T-score > 5 on the PHQ-9).
- Mothers must have a child between the ages of 8 and 12 years old.
- Both mothers and children must currently live in Manitoba.
- Mothers must self-report that their child has a diagnosis of ADHD. This will be confirmed by having mothers complete the CBCL (T-score > 65) and through intake interviews with clinicians.
- Both mothers and children must speak fluent English.
- Mothers must have neither attempted suicide within the past year nor self-harmed resulting in an injury that either did or should have received medical attention within the past 6 months.
Who cannot join
- not meeting the listed criteria above
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site
University of Manitoba
Winnipeg, Manitoba, R3T 2N2
Tasmia Hai, PhD, 4166609291, tasmia.hai@umanitoba.ca
tasmia.hai@umanitoba.ca
About this study
The present research study will evaluate the feasibility and preliminary efficacy of the adapted Building Regulation in Dual Generations program for families of children (8-12 years old) with Attention-Deficit/Hyperactivity Disorder, creating the BRIDGE-ADHD program. The BRIDGE-ADHD program combines 10 weekly online psycho-education sessions with knowledge about ADHD and relevant parenting skills training videos to improve maternal wellbeing and parenting practices, thus supporting children's own psychological wellbeing through an intergenerational approach. This study will specifically evaluate whether the BRIDGE-ADHD program is able to reduce mothers' psychological distress (e.g., depression, anxiety, parenting stress) and simultaneously reduce their children's attention and/or behaviour problems.
Read the detailed description
Families of children with attention-deficit/hyperactivity disorder (ADHD) often experience elevated parenting stress. Maternal psychological distress (e.g., symptoms of depression and anxiety) is associated with harsher parenting practices that may increase children's risk for both externalizing and internalizing behaviour problems, including ADHD symptoms such as hyperactivity, impulsivity, and inattention. ADHD is in turn associated with deficits in self-regulation and executive functioning, which tend to result in social and academic difficulties that negatively impact the lives of children and families.
Supporting parents through effective parenting strategies is a key modifiable factor that can reduce child behavioural difficulties. Improving parent mental health by reducing parenting stress through skills-based parenting and psychoeducation may reduce parental distress and improve family functioning.
The Building Regulation in Dual Generations program (BRIDGE) for ADHD program is designed to provide mothers with mental health support and parenting skills that promote more effective management of their child's ADHD symptoms and, ultimately, reduce attention and behaviour problems through improvements in self-regulation. BRIDGE-ADHD is an adapted 10 week program that aims to support intergenerational emotion regulation and positive parenting strategies. The program combines dialectical behaviour therapy (DBT) skills with parenting-focused psychoeducational content. Each week, participants will attend a 1.5 hour synchronous online group session led by a licensed clinical psychologist, co facilitated by clinical psychology graduate students under supervision, and a peer parent coach who has previously participated in the BRIDGE program.
This study will use a non-randomized, parallel-assignment feasibility pilot design to evaluate the feasibility and potential efficacy of BRIDGE-ADHD in addressing parenting stress and children's attentional and behavioural problems. We will recruit thirty parent-child dyads (15 intervention participants and 15 normative controls). Participants in the intervention group will complete the 10 week online BRIDGE-ADHD program and in person assessments at two time points: pre intervention (week 0-1; T0) and post intervention (week 10; T1). The normative control group will complete the same in person assessments without participating in the intervention. The primary aim is to examine the feasibility and acceptability of BRIDGE-ADHD and its impact on maternal mental health and children's social-emotional development.
Secondary aims are to evaluate the program's efficacy in reducing parenting stress and decreasing harsh parenting tendencies. Exploratory aims include examining differences or changes in sleep quality, mental well-being, relationships, and child academic achievement before and after participation in BRIDGE-ADHD.
- Conditions
- ADHD, Maternal Mental Health, Dialectical Behavior Therapy, Parenting Intervention, Children
- Being tested
- BRIDGE-ADHD
- Keywords
- ADHD, Parenting, online therapy, DBT skills, children
- Medical subject headings
- Attention Deficit Disorder with Hyperactivity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BRIDGE-ADHDBehavioural
The BRIDGE-ADHD program is a 10-week program that combines online psychoeducation sessions with parenting manual handouts and parenting skills training videos to improve maternal wellbeing and promote positive parenting practices tailored to the needs of families of children with ADHD. The BRIDGE-ADHD program content is largely based on mindfulness and dialectical behaviour therapy (DBT) skills, including emotion regulation, distress tolerance, and other related skills. The program will also include psycho-education on ADHD and parenting skills
| Study group | Role | What they receive |
|---|---|---|
| BRIDGE-ADHD | Experimental | The group that will receive the BRIDGE-ADHD program Receives: Behavioral: BRIDGE-ADHD |
| Normative Control | No intervention | This is a normative control group who will not be receiving any intervention. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in child mental health symptoms following BRIDGE-ADHD intervention
Changes in child mental health symptoms will be measured using the Child Behavior Checklist (CBCL) for ages 6 to 18. The CBCL is a 100-item parent-report questionnaire with a range of scores from 0 to 200, measuring child functioning across externalizing and internalizing symptoms. All raw scores are converted into T-scores across all domains tested to have a standardized outcome. Higher T-scores indicate greater symptom severity. We will use the CBCL to assess a) total behaviour problems, b) ADHD subscale scores, c) internalizing behaviours, and d) externalizing behaviours. These subscale scores will collectively be investigated as child mental health symptoms.
Measured: This measure will be administered at baseline, (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention which will occur between weeks 11-12 (noted as T1).
Changes in maternal depressive symptoms
Depressive symptoms will be measured using the Patient Health Questionnaire 9-Item (PHQ-9). The PHQ-9 is a 9-item self-report questionnaire with a range of scores from 0 to 27. Higher scores indicate greater symptom severity.
Measured: This measure will be administered at baseline, which is considered week 0-1 (noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention taking place at weeks 11-12 ( noted as T1).
Maternal ratings of program acceptability
Maternal ratings of program acceptability will be collected using an open-ended program acceptability questionnaire developed by the research team. Participants will rate how important various components of the program were to them and will be asked to respond to open-ended questions regarding their experience in the program.
Measured: This measure will be administered after the 10 week of BRIDGE intervention, post-intervention (noted as T1) expected to take place sometime between weeks 11-12.
Recruitment Feasibility Metrics
The feasibility of the BRIDGE-ADHD program will be evaluated using a range of implementation metrics. Recruitment feasibility will be assessed by examining eligibility rates, enrollment rates, and the time required to recruit the target sample. All of these measures will be presented in rates allowing for common measurement across domains.
Measured: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
Data Collection Feasibility
The feasibility of the BRIDGE-ADHD program will be evaluated using a range of implementation metrics. Data collection feasibility will be determined by the proportion of participants completing baseline and post-intervention assessments, rates of missing data, and the time required to complete study measures.
Measured: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
Program Implementation Outcomes
Program implementation outcomes, including session attendance, reasons for missed sessions or withdrawal, scheduling challenges, technological issues and facilitator reflections on program delivery
Measured: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
Program Retention Measure
Retention and adherence will be measured by the proportion of participants who complete the program, attendance rates across the 10 sessions, and watching home videos, where applicable.
Measured: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
Secondary outcomes (10)
Changes in parent ratings of child behaviours
Changes in parent ratings of child behaviours will be measured using the Behaviour Assessment System for Children - Third Edition (BASC-3). The BASC-3 is a parent-report questionnaire measuring externalizing and internalizing problems, attention problems, school problems, as well as adaptive strengths like social skills and study skills. All raw scores are converted into T-scores across all domains tested to have a standardized outcome. Higher T-scores on problem factors indicate more severe problems. Higher T-scores on strengths indicate more of those strengths. We will be specifically looking at broader subscale scores to identify if there has been any change in child behaviours.
Measured: This measure will be administered at baseline, (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention which will occur between weeks 11-12 (noted as T1).
Changes in Parenting stress
Parenting stress will be measured using the Parenting Stress Index Short Form (PSI-SF). The PSI-SF is a self-report questionnaire requiring respondents to answer questions regarding their overall experience of parenting stress using a 5-point Likert with a range of scores range from 36 to 180. All raw scores are converted into T-scores across all domains tested to have a standardized outcome. Higher T-scores indicate higher levels of parenting stress. Changes in total parenting stress score will be measured.
Measured: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in difficulties with maternal emotion regulation
Changes in difficulties with emotion regulation will be measured using the Difficulties in Emotion Regulation 36-Item Scale (DERS-36). The DERS-36 is a self-report questionnaire assessing emotion dysregulation across 6 dimensions, including nonacceptance of emotions, difficulties with goal-directed behaviour, impulse control, lack of emotional awareness, limited access to regulation strategies, and lack of emotional clarity. Respondents rate often each statement describes them on a 5-point Likert scale with higher scores indicating greater difficulties. All raw scores are converted into T-scores across all domains tested to have a standardized outcome. Total scores range from 36 to 180 with higher score indicating greater overall difficulties with emotion regulation. Changes in total emotion regulation T-score will be measured.
Measured: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in maternal feelings of anger
Changes in anger will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Anger subscale. The PROMIS Anger subscale contains 5 items with a range of scores from 5 to 25. Higher scores indicate higher levels of anger.
Measured: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in maternal sleep problems
Changes in maternal sleep disturbances will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance subscale short form. The subscale contains 8 items with a range of scores from 8 to 40. Higher scores indicate greater sleep disturbance severity.
Measured: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in children's sleep habits
Changes in children's sleep habits will be measured using the Children's Sleep Habits Questionnaire (CSHQ). The CSHQ is a 45-item parent-report questionnaire assessing common sleep problems in children aged 4 to 12, including bedtime resistance and night waking. Higher scores indicate more severe sleep problems with scores above 41 suggesting clinical concerns.
Measured: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in maternal anxiety symptoms
Anxiety symptoms will be measured using the Generalized Anxiety Disorder 7-Item Scale (GAD-7). The GAD-7 contains 7 items with a range of scores from 0 to 21. Higher scores indicate higher levels of anxiety symptoms.
Measured: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in maternal Attention and Hyperactivity symptoms
Changes in maternal ADHD symptoms will be measured using the Adult ADHD Self-Report Scale (ASRS). The ASRS is an 18-item questionnaire screening for ADHD symptoms in adults based on DSM criteria. Part A of the scale contains 6 items screening for the most predictive symptoms and Part B collects additional details. Total scores range from 0 to 72 with higher scores indicating greater frequency and severity of ADHD symptoms. All raw scores are converted into T-scores across all domains tested to have a standardized outcome.
Measured: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Measure of Child health
Child health will be assessed using a parent-report questionnaire developed by the research team. Parents will be asked to respond to questions about their child's physical and mental health from birth to the present.
Measured: This measure will be administered at baseline (noted as T0), expected to occur sometime between weeks 0-1.
Changes in harsh parenting
Changes in harsh parenting will be measured using the Behaviour Assessment System for Children - Third Edition (BASC-3) Parenting Relationship Questionnaire. The BASC-3 is an 87-item parent-report questionnaire for children aged 2 to 18 years with 7 parenting behaviour subscales, including communication and involvement. Higher scores indicate more of the relevant subscale. Specifically, change in harsh parenting will be measured. All raw scores are converted into T-scores across all domains tested to have standardized outcomes.
Measured: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Nov 2026
- Study start1 Nov 2026 (estimated)
- Primary completion31 May 2027 (estimated)
- Study completion31 May 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for ADHDStudies of the same condition, open and under way.
- More trials run by University of ManitobaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Model description
- One clinical group receives treatment; a separate normative group provides reference data and is not assigned to a treatment condition. the normative group is recruited separately and does not undergo treatment
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Manitoba
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Tasmia Hai, University of Manitoba
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07926776
- Sponsor's protocol ID
- HE2026-0071
- Acronym
- BRIDGE-ADHD
- Status last verified
- Aug 2026
- First submitted
- 6 Aug 2026
- Last updated
- 9 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Given the sensitive nature of the data, we have not decided whether the data can be shared or not.
Publications
Theule, J., Wiener, J., Tannock, R., & Jenkins, J. M. (2010). Parenting stress in families of children with ADHD: A meta-analysis. Journal of Emotional and Behavioral Disorders, 21(1), 3-17. https://doi.org/10.1177/1063426610387433
Wolraich ML, Hagan JF Jr, Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W; SUBCOMMITTEE ON CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVE DISORDER. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019 Oct;144(4):e20192528. doi: 10.1542/peds.2019-2528.
PubMed 31570648Roos LE, Kaminski L, Stienwandt S, Hunter S, Giuliano R, Mota N, Katz LY, Zalewski M. The Building Regulation in Dual-Generations Program (BRIDGE): A Mixed-Methods Feasibility Pilot of a Parenting Program for Depressed Mothers of Preschoolers, Matched with Dialectical Behavior Therapy Skills. Child Psychiatry Hum Dev. 2023 Feb;54(1):34-50. doi: 10.1007/s10578-021-01219-1. Epub 2021 Aug 4.
PubMed 34347227Pinquart M. Associations of parenting dimensions and styles with externalizing problems of children and adolescents: An updated meta-analysis. Dev Psychol. 2017 May;53(5):873-932. doi: 10.1037/dev0000295.
PubMed 28459276Penner-Goeke L, Belows M, Kristjanson A, Andrade BF, Cameron EE, Giuliano R, Katz LY, Kelly LE, Letourneau N, Mota N, Reynolds K, Zalewski M, Pharazyn A, Roos LE. Protocol for a randomized control trial of the Building Regulation in Dual Generations Program (BRIDGE): preventing the intergenerational transmission of mental illness in at-risk preschool children. Trials. 2023 Sep 19;24(1):597. doi: 10.1186/s13063-023-07591-8.
PubMed 37726821Mingebach T, Kamp-Becker I, Christiansen H, Weber L. Meta-meta-analysis on the effectiveness of parent-based interventions for the treatment of child externalizing behavior problems. PLoS One. 2018 Sep 26;13(9):e0202855. doi: 10.1371/journal.pone.0202855. eCollection 2018.
PubMed 30256794Hong Y, Bertrand CM, Deater-Deckard K, Smith CL, Bell MA. The role of mother's and child's self-regulation on bidirectional links between harsh parenting and child externalizing problems. Dev Psychol. 2024 Mar;60(3):441-455. doi: 10.1037/dev0001661. Epub 2024 Jan 22.
PubMed 38252104Heard, H. L., & Linehan, M. M. (1994). Dialectical behavior therapy: An integrative approach to the treatment of borderline personality disorder. Journal of Psychotherapy Integration, 4(1), 55-82. https://doi.org/10.1037/h0101147
Study at a glance
From the registry record, last updated by the sponsor on 9 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Supporting Families of School-Aged Children With ADHD: A Dual-Generation Therapy Approach Through the BRIDGE Program
- ClinicalTrials.gov ID
- NCT07926776
- Acronym / sponsor ID
- BRIDGE-ADHD / HE2026-0071
- Conditions
- ADHD, Maternal Mental Health, Dialectical Behavior Therapy, Parenting Intervention, Children
- Keywords
- ADHD, Parenting, online therapy, DBT skills, children
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- University of ManitobaUniversity, hospital or other
- Study start
- 1 Nov 2026 (estimated)
- Primary completion
- 31 May 2027 (estimated)
- Study completion
- 31 May 2028 (estimated)
- First posted
- 9 Nov 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The present research study will evaluate the feasibility and preliminary efficacy of the adapted Building Regulation in Dual Generations program for families of children (8-12 years old) with Attention-Deficit/Hyperactivity Disorder, creating the BRIDGE-ADHD program. The BRIDGE-ADHD program combines 10 weekly online psycho-education sessions with knowledge about ADHD and relevant parenting skills training videos to improve maternal wellbeing and parenting practices, thus supporting children's own psychological wellbeing through an intergenerational approach. This study will specifically evaluate whether the BRIDGE-ADHD program is able to reduce mothers' psychological distress (e.g., depression, anxiety, parenting stress) and simultaneously reduce their children's attention and/or behaviour problems.
Detailed description
Families of children with attention-deficit/hyperactivity disorder (ADHD) often experience elevated parenting stress. Maternal psychological distress (e.g., symptoms of depression and anxiety) is associated with harsher parenting practices that may increase children's risk for both externalizing and internalizing behaviour problems, including ADHD symptoms such as hyperactivity, impulsivity, and inattention. ADHD is in turn associated with deficits in self-regulation and executive functioning, which tend to result in social and academic difficulties that negatively impact the lives of children and families.
Supporting parents through effective parenting strategies is a key modifiable factor that can reduce child behavioural difficulties. Improving parent mental health by reducing parenting stress through skills-based parenting and psychoeducation may reduce parental distress and improve family functioning.
The Building Regulation in Dual Generations program (BRIDGE) for ADHD program is designed to provide mothers with mental health support and parenting skills that promote more effective management of their child's ADHD symptoms and, ultimately, reduce attention and behaviour problems through improvements in self-regulation. BRIDGE-ADHD is an adapted 10 week program that aims to support intergenerational emotion regulation and positive parenting strategies. The program combines dialectical behaviour therapy (DBT) skills with parenting-focused psychoeducational content. Each week, participants will attend a 1.5 hour synchronous online group session led by a licensed clinical psychologist, co facilitated by clinical psychology graduate students under supervision, and a peer parent coach who has previously participated in the BRIDGE program.
This study will use a non-randomized, parallel-assignment feasibility pilot design to evaluate the feasibility and potential efficacy of BRIDGE-ADHD in addressing parenting stress and children's attentional and behavioural problems. We will recruit thirty parent-child dyads (15 intervention participants and 15 normative controls). Participants in the intervention group will complete the 10 week online BRIDGE-ADHD program and in person assessments at two time points: pre intervention (week 0-1; T0) and post intervention (week 10; T1). The normative control group will complete the same in person assessments without participating in the intervention. The primary aim is to examine the feasibility and acceptability of BRIDGE-ADHD and its impact on maternal mental health and children's social-emotional development.
Secondary aims are to evaluate the program's efficacy in reducing parenting stress and decreasing harsh parenting tendencies. Exploratory aims include examining differences or changes in sleep quality, mental well-being, relationships, and child academic achievement before and after participation in BRIDGE-ADHD.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- One clinical group receives treatment; a separate normative group provides reference data and is not assigned to a treatment condition. the normative group is recruited separately and does not undergo treatment
| Arm | Type | Receives |
|---|---|---|
| BRIDGE-ADHD | Experimental | Behavioral: BRIDGE-ADHDThe group that will receive the BRIDGE-ADHD program |
| Normative Control | No intervention | –This is a normative control group who will not be receiving any intervention. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Mothers must be 18 years old or older with both current and elevated symptoms of depression (T-score > 5 on the PHQ-9).
Key exclusion criteria (1 listed)
- not meeting the listed criteria above
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BRIDGE-ADHDThe BRIDGE-ADHD program is a 10-week program that combines online psychoeducation sessions with parenting manual handouts and parenting skills training videos to improve maternal wellbeing and promote positive parenting practices tailored to the needs of families of children with ADHD. The BRIDGE-ADHD program content is largely based on mindfulness and dialectical behaviour therapy (DBT) skills, including emotion regulation, distress tolerance, and other related skills. The program will also include psycho-education on ADHD and parenting skills | Behavioural | BRIDGE-ADHD |
Primary outcome
Changes in child mental health symptoms following BRIDGE-ADHD intervention
Time frame: This measure will be administered at baseline, (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention which will occur between weeks 11-12 (noted as T1).
Changes in child mental health symptoms will be measured using the Child Behavior Checklist (CBCL) for ages 6 to 18. The CBCL is a 100-item parent-report questionnaire with a range of scores from 0 to 200, measuring child functioning across externalizing and internalizing symptoms. All raw scores are converted into T-scores across all domains tested to have a standardized outcome. Higher T-scores indicate greater symptom severity. We will use the CBCL to assess a) total behaviour problems, b) ADHD subscale scores, c) internalizing behaviours, and d) externalizing behaviours. These subscale scores will collectively be investigated as child mental health symptoms.
Changes in maternal depressive symptoms
Time frame: This measure will be administered at baseline, which is considered week 0-1 (noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention taking place at weeks 11-12 ( noted as T1).
Depressive symptoms will be measured using the Patient Health Questionnaire 9-Item (PHQ-9). The PHQ-9 is a 9-item self-report questionnaire with a range of scores from 0 to 27. Higher scores indicate greater symptom severity.
Maternal ratings of program acceptability
Time frame: This measure will be administered after the 10 week of BRIDGE intervention, post-intervention (noted as T1) expected to take place sometime between weeks 11-12.
Maternal ratings of program acceptability will be collected using an open-ended program acceptability questionnaire developed by the research team. Participants will rate how important various components of the program were to them and will be asked to respond to open-ended questions regarding their experience in the program.
Recruitment Feasibility Metrics
Time frame: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
The feasibility of the BRIDGE-ADHD program will be evaluated using a range of implementation metrics. Recruitment feasibility will be assessed by examining eligibility rates, enrollment rates, and the time required to recruit the target sample. All of these measures will be presented in rates allowing for common measurement across domains.
Data Collection Feasibility
Time frame: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
The feasibility of the BRIDGE-ADHD program will be evaluated using a range of implementation metrics. Data collection feasibility will be determined by the proportion of participants completing baseline and post-intervention assessments, rates of missing data, and the time required to complete study measures.
Program Implementation Outcomes
Time frame: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
Program implementation outcomes, including session attendance, reasons for missed sessions or withdrawal, scheduling challenges, technological issues and facilitator reflections on program delivery
Program Retention Measure
Time frame: These will be measured from beginning of the study recruitment till the end of the pilot trial. This time frame can be up to 1 year.
Retention and adherence will be measured by the proportion of participants who complete the program, attendance rates across the 10 sessions, and watching home videos, where applicable.
10 secondary outcomes
Changes in parent ratings of child behaviours
Time frame: This measure will be administered at baseline, (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention which will occur between weeks 11-12 (noted as T1).
Changes in Parenting stress
Time frame: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in difficulties with maternal emotion regulation
Time frame: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in maternal feelings of anger
Time frame: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in maternal sleep problems
Time frame: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in children's sleep habits
Time frame: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in maternal anxiety symptoms
Time frame: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Changes in maternal Attention and Hyperactivity symptoms
Time frame: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Measure of Child health
Time frame: This measure will be administered at baseline (noted as T0), expected to occur sometime between weeks 0-1.
Changes in harsh parenting
Time frame: This measure will be administered at baseline (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention, which will occur between weeks 11-12 (noted as T1).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Nov 2026.
- BackgroundTheule, J., Wiener, J., Tannock, R., & Jenkins, J. M. (2010). Parenting stress in families of children with ADHD: A meta-analysis. Journal of Emotional and Behavioral Disorders, 21(1), 3-17. https://doi.org/10.1177/1063426610387433
- Background: PubMed 31570648Wolraich ML, Hagan JF Jr, Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W; SUBCOMMITTEE ON CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVE DISORDER. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019 Oct;144(4):e20192528. doi: 10.1542/peds.2019-2528.
- Background: PubMed 34347227Roos LE, Kaminski L, Stienwandt S, Hunter S, Giuliano R, Mota N, Katz LY, Zalewski M. The Building Regulation in Dual-Generations Program (BRIDGE): A Mixed-Methods Feasibility Pilot of a Parenting Program for Depressed Mothers of Preschoolers, Matched with Dialectical Behavior Therapy Skills. Child Psychiatry Hum Dev. 2023 Feb;54(1):34-50. doi: 10.1007/s10578-021-01219-1. Epub 2021 Aug 4.
- Background: PubMed 28459276Pinquart M. Associations of parenting dimensions and styles with externalizing problems of children and adolescents: An updated meta-analysis. Dev Psychol. 2017 May;53(5):873-932. doi: 10.1037/dev0000295.
- Background: PubMed 37726821Penner-Goeke L, Belows M, Kristjanson A, Andrade BF, Cameron EE, Giuliano R, Katz LY, Kelly LE, Letourneau N, Mota N, Reynolds K, Zalewski M, Pharazyn A, Roos LE. Protocol for a randomized control trial of the Building Regulation in Dual Generations Program (BRIDGE): preventing the intergenerational transmission of mental illness in at-risk preschool children. Trials. 2023 Sep 19;24(1):597. doi: 10.1186/s13063-023-07591-8.
- Background: PubMed 30256794Mingebach T, Kamp-Becker I, Christiansen H, Weber L. Meta-meta-analysis on the effectiveness of parent-based interventions for the treatment of child externalizing behavior problems. PLoS One. 2018 Sep 26;13(9):e0202855. doi: 10.1371/journal.pone.0202855. eCollection 2018.
- Background: PubMed 38252104Hong Y, Bertrand CM, Deater-Deckard K, Smith CL, Bell MA. The role of mother's and child's self-regulation on bidirectional links between harsh parenting and child externalizing problems. Dev Psychol. 2024 Mar;60(3):441-455. doi: 10.1037/dev0001661. Epub 2024 Jan 22.
- BackgroundHeard, H. L., & Linehan, M. M. (1994). Dialectical behavior therapy: An integrative approach to the treatment of borderline personality disorder. Journal of Psychotherapy Integration, 4(1), 55-82. https://doi.org/10.1037/h0101147
- Individual participant dataSharing planned: Undecided. Given the sensitive nature of the data, we have not decided whether the data can be shared or not.
Related trials for ADHD
RecruitingObservational study
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
Irritability, Disruptive Mood Dysregulation Disorder
RecruitingObservational study
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Disruptive Behavior Disorders, Conduct Disorder
RecruitingPhase 3
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
Recruiting
AI-assisted Home-based Intervention for ADHD Children
ADHD - Attention Deficit Disorder With Hyperactivity, ADHD - Combined Type
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing BRIDGE-ADHD in people with ADHD and Maternal Mental Health, run by University of Manitoba at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 9 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Tasmia Hai, PhD (14166609291, tasmia.hai@umanitoba.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in child mental health symptoms following BRIDGE-ADHD intervention (time frame: This measure will be administered at baseline, (week 0-1; noted as T0) and after 10 weeks of BRIDGE intervention, post-intervention which will occur between weeks 11-12 (noted as T1).). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07926776, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Nov 2026.